A second case of HIV remission
RI-MUHC researchers consulted on implications for HIV research
International team of scientists detect cause of rare pediatric brain disorder
RI-MUHC pediatric researcher joins efforts with scientists from the Rady Children’s Institute for Genomic Medicine to discover new mutation
Viral communications hacking boosts Leishmania infections
New study sheds light on viral biology, could lead to efficient vaccines against a tropical disease
Shared genetic marker offers new promise in targeting specific ovarian and lung cancers
Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer
A hide-out for viruses in the testicles
RI-MUHC team leads an innovative study using testicular tissue to unlock the secrets of the immune system...
Quebec researchers among recipients of $34 million “Grand Challenge” Grant from Cancer Research UK to combat cancer
Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer
Confronting a killer
Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...
Heart & Stroke honours RI-MUHC researcher
On November 14, the Heart and Stroke Foundation honoured three researchers – including two McGill faculty members – with an award...
Innovative biosensor technology reveals secrets of how drugs work
What if we could take advantage of a drug’s benefit without side effects? Stéphane Laporte, PhD is conducting research in his laboratory at the Glen...
RI-MUHC scientist receives Terry Fox funding to study metastatic sarcomas
As Terry Fox approached the city of Thunder Bay in Ontario on Sept. 1, 1980, a strange pain took hold of his chest. The 22-year-old had been...